AGY vs. ANCR, BXP, CEL, EAH, APH, VLG, BMK, EKF, CREO, and 4BB
Should you be buying Allergy Therapeutics stock or one of its competitors? The main competitors of Allergy Therapeutics include Animalcare Group (ANCR), Beximco Pharmaceuticals (BXP), Celadon Pharmaceuticals (CEL), ECO Animal Health Group (EAH), Alliance Pharma (APH), Venture Life Group (VLG), Benchmark (BMK), EKF Diagnostics (EKF), Creo Medical Group (CREO), and 4basebio (4BB). These companies are all part of the "medical" sector.
Allergy Therapeutics (LON:AGY) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, community ranking, risk, media sentiment and institutional ownership.
Allergy Therapeutics has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, Animalcare Group has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500.
Allergy Therapeutics received 207 more outperform votes than Animalcare Group when rated by MarketBeat users. Likewise, 77.97% of users gave Allergy Therapeutics an outperform vote while only 69.37% of users gave Animalcare Group an outperform vote.
0.1% of Allergy Therapeutics shares are owned by institutional investors. Comparatively, 44.7% of Animalcare Group shares are owned by institutional investors. 93.2% of Allergy Therapeutics shares are owned by company insiders. Comparatively, 29.7% of Animalcare Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Animalcare Group has a net margin of 1.61% compared to Allergy Therapeutics' net margin of -72.28%. Animalcare Group's return on equity of 1.53% beat Allergy Therapeutics' return on equity.
Animalcare Group has higher revenue and earnings than Allergy Therapeutics. Allergy Therapeutics is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Allergy Therapeutics had 1 more articles in the media than Animalcare Group. MarketBeat recorded 1 mentions for Allergy Therapeutics and 0 mentions for Animalcare Group. Allergy Therapeutics' average media sentiment score of 0.64 beat Animalcare Group's score of 0.00 indicating that Allergy Therapeutics is being referred to more favorably in the media.
Summary
Animalcare Group beats Allergy Therapeutics on 8 of the 15 factors compared between the two stocks.
Get Allergy Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AGY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Allergy Therapeutics Competitors List
Related Companies and Tools
